Newsroom

Sorted by: Latest

-

NiSource to Release Third Quarter 2026 Financial Results and Host Conference Call on October 28

MERRILLVILLE, Ind.--(BUSINESS WIRE)--NiSource Inc. (NYSE: NI) today announced that the company will release third quarter 2026 financial results on October 28, 2026, before US financial markets open and will host a conference call that day at 11 a.m. EDT (10 a.m. CT) to review third quarter 2026 financial results and provide a general business update. All interested parties may listen to the conference call live on October 28 by logging onto the NiSource website at www.nisource.com. A link on t...
-

The Chemours Company (CC) Investors: December 7, 2026, Deadline in Securities Fraud Class Action Lawsuit – Contact Kessler Topaz Meltzer & Check, LLP

RADNOR, Pa.--(BUSINESS WIRE)--Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, informs investors that a securities fraud class action lawsuit has been filed against The Chemours Company (“Chemours”) (NYSE: CC) on behalf of those who purchased or acquired Chemours securities between February 20, 2026 and August 4, 2026, inclusive. The lawsuit is filed in the United States District Court for the District of Delaware and is captioned Da...
-

KBRA Assigns Preliminary Ratings to CROSS 2026-NQM12 Mortgage Trust

NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to ten classes of mortgage pass-through certificates from CROSS 2026-NQM12 Mortgage Trust, an RMBS transaction issued under the CROSS shelf, where Hildene-CCC Loan Acquisition II, LLC and CrossCountry Capital are the co-sponsors. This $663.3 million transaction is collateralized by a pool of 1,361 residential mortgages, including a meaningful concentration of collateral that KBRA considers to be “non-prime” (77.7%), with fixed-rate mor...
-

FDA Expands ANKTIVA® Approval for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer to Cover Both Papillary and CIS Disease

CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that the U.S. Food and Drug Administration (FDA) has expanded the approved indication for ANKTIVA® (nogapendekin alfa inbakicept-pmln) in combination with Bacillus Calmette-Guérin (BCG) to include patients with BCG-unresponsive NMIBC with papillary-only tumors. The expanded FDA label reads as follows: ANKTIVA, in combination with Bacillus Calmette-Guérin (BCG), is in...
-

Publix Announces Officer Retirement and Promotions in Industrial Operations and Finance

LAKELAND, Fla.--(BUSINESS WIRE)--Publix CEO Kevin Murphy announced officer promotions effective Jan. 1, 2027, and the retirement of Senior Vice President of Industrial Operations Mike Smith. Smith plans to retire at the end of the year after 43 years of dedicated service. With Smith’s retirement, Vice President of Distribution and Transportation Mike Lester will be promoted to senior vice president of industrial operations, and Director of Transportation and Maintenance James Sadler will be pro...
-

BXP Completes Initial Sale of Partial Interest in 343 Madison Avenue Development

BOSTON--(BUSINESS WIRE)--BXP, Inc. (NYSE: BXP), the largest publicly traded developer, owner, and manager of premier workplaces in the United States, announced today that it has closed the sale of a 10.6% equity interest in the development of 343 Madison Avenue in Midtown Manhattan, New York, to AVRS Partners, a New York-based real estate investment firm specializing in identifying and acquiring exceptional real estate assets across the United States and Europe. “343 Madison Avenue demonstrates...
-

UDR, Inc. Announces Appointment of Scott McCallum as Executive Vice President – Chief Investment Officer

DENVER--(BUSINESS WIRE)--UDR, Inc. (the “Company”) (NYSE: UDR), a leading multifamily real estate investment trust, today announced that Scott McCallum will join the Company as Executive Vice President - Chief Investment Officer (“EVP-CIO”), effective November 5, 2026. He will report to Thomas W. Toomey, Chairman, President, and Chief Executive Officer of UDR. Mr. McCallum will bring an extensive background in public and private real estate with a decade of experience in real estate investments...
-

KKR Real Estate Finance Trust Inc. to Announce Third Quarter 2026 Results

NEW YORK--(BUSINESS WIRE)--KKR Real Estate Finance Trust Inc. (“KREF”) (NYSE: KREF) announced today that it plans to release its financial results for the third quarter 2026 on Wednesday, October 28, 2026, after the close of trading on the New York Stock Exchange. A conference call to discuss KREF’s financial results will be held on Thursday, October 29, 2026 at 11:00 a.m. ET. The conference call may be accessed by dialing (800) 715-9871 (U.S. callers) or (646) 307-1963 (non-U.S. callers toll);...
-

Don Templin Elected to Jackson’s Board of Directors

LANSING, Mich.--(BUSINESS WIRE)--Jackson Financial Inc.i (NYSE: JXN) (Jackson®) announced today that its Board of Directors has elected Donald C. (“Don”) Templin as a new independent director. He was also appointed as a member of the Board’s Audit and Compensation committees. “I am pleased to welcome Don to Jackson’s Board of Directors,” said Steve Kandarian, independent chair of the Jackson board. “His experience as a financial leader in the insurance and energy industries, combined with his e...
-

Equity Bancshares, Inc. Third Quarter Results Highlighted by Organic Loan Growth and Announced Merger with Lincoln Bancorp

WICHITA, Kan.--(BUSINESS WIRE)--Equity Bancshares, Inc. (NYSE: EQBK) (“Equity”, “the Company,” “we,” “us,” “our”), the Wichita-based holding company of Equity Bank, reported net income of $26.8 million or $1.29 per diluted share for the quarter ended September 30, 2026. Core earnings per diluted share for the quarter was $1.40. “This quarter our company continued to execute at an exciting level. Earnings were strong, production reached all-time highs and loans grew organically. We are putting t...